Composition of Gangliosides and Neutral Glycosphingolipids of Brain in Classical Tay‐Sachs and Sandhoff Disease: More Lyso‐GM2 in Sandhoff Disease?
Authors:
- 1 September 1987
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 49 (3) , 834-840
Abstract
The ganglioside composition of the brain from an individual with classical Tay‐Sachs disease and from an individual with Sandhoff disease was examined using our new quantitative methods for ganglioside content determination and compared with that of age‐matched control brains. The concentration of GM2 was found to be 12.2 and 13.0 μmol/ g of fresh tissue in Tay‐Sachs disease and in Sandhoff disease cerebral gray matter, respectively. GM2 was 86 and 87% respectively, of total gangliosides. The concentration of GM1 and, in particular, GM3 ganglioside was also found to be increased, whereas the concentration of the major di‐ and trisialogangliosides (GD1a, GD1b, and GT1b) had diminished markedly. There was no significant increase in level of any other ganglioside than lyso‐GM2. Its concentration was 12 and 16 nmol/g in cerebral gray matter of two Tay‐Sachs disease brains and 43 nmol/g in Sandhoff disease brain. The SandhofF disease brain also differed from the classical Tay‐ Sachs disease brain by having a much higher concentration of gangliotriaosylceramide and globotetraosylceramide. The structures of relevant gangliosides and neutral glycolipids were established by fast atom bombardment‐mass spectrometry and permethylation studies.Keywords
This publication has 29 references indexed in Scilit:
- Trisialosyllactosylceramide (GT3) is a ganglioside of human lungFEBS Letters, 1986
- The Biochemical Basis of GangliosidosesNeuropediatrics, 1984
- Separation of gangliosides on a new type of anion-exchange resinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- A procedure for the quantitative isolation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- GANGLIOSIDE1−COMPOSITION OF BRAIN IN TAY‐SACHS DISEASE: INCREASED AMOUNTS OF GD2 AND N‐ACETYL‐β‐D‐GALACTOSAMINYL GD1a GANGLIOSIDEJournal of Neurochemistry, 1979
- A simple and novel method for tritium labeling of gangliosides and other sphingolipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Gangliosides of human, bovine and rabbit retinaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- Variation of β‐N‐acetylhexosaminidase‐pattern in Tay‐Sachs diseaseFEBS Letters, 1969
- The chemical structure of normal human brain and Tay-Sachs gangliosidesBiochemical and Biophysical Research Communications, 1962
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957